US Cancer Centers of Excellence Strategies for Increased Inclusion of Racial and Ethnic Minorities in Clinical Trials

201993 citationsJournal Articlehybrid Open Access

Authors

Jeanne M. Regnante

Nicole Richie

Lola A. Fashoyin‐Aje · United States Food and Drug Administration

Michelle Vichnin · Merck & Co., Inc., Rahway, NJ, USA (United States)

Marvella E. Ford · MUSC Hollings Cancer Center

Upal Roy · LUNGevity Foundation

K. C. Turner · Johnson & Johnson (United States)

Laura Lee Hall

Abstract

We have identified notable practices that facilitate increased participation of REMGs in cancer trials. Wide implementation of such strategies across cancer centers is essential to ensure that all populations benefit from advances in an era of increasingly personalized treatment of cancer.

Topics & Keywords

Ethics in Clinical Research Global Cancer Incidence and Screening Palliative Care and End-of-Life Issues

UN Sustainable Development Goals

Reduced inequalities

Publication Details

Published in: Journal of Oncology Practice

Volume 15, Issue 4, pp. e289-e299

DOI: 10.1200/jop.18.00638

Field-Weighted Citation Impact: 13.18